Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts

BACKGROUND: Intestinal fibrosis is a serious complication of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. There is no specific treatment for intestinal fibrosis. Studies have indicated that peroxisome proliferator-activated receptor- γ (PPAR-γ) agonists have anti-fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Jun Bon, Nam, Myeong-Ok, Jung, Younshin, Yoo, Jongman, Kim, Duk Hwan, Kim, Gwangil, Shin, Sung Jae, Lee, Kee Myung, Hahm, Ki Baik, Kim, Jong Woo, Hong, Sung Pyo, Lee, Kwang Jae, Yoo, Jun Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463383/
https://www.ncbi.nlm.nih.gov/pubmed/28592228
http://dx.doi.org/10.1186/s12876-017-0627-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463383/
https://www.ncbi.nlm.nih.gov/pubmed/28592228
http://dx.doi.org/10.1186/s12876-017-0627-4

Ejemplares similares